In this study, the 8-week W. coagulans BC99 intervention significantly improved constipation symptoms, enhanced the quality of life, increased the levels of neurotransmitters (5-HT, MTL, AChE, and BDNF) positively associated with intestinal motility, and declined inflammation levels in adults with constipation. This evidence concerns the gene ACHE and constipation disorder.